Funding Rounds
Sitryx Therapeutics

Sitryx Therapeutics Series A (2023, $38M)

Sitryx Therapeutics

Developer of therapeutics for chronic autoimmune and inflammatory diseases.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $38.83M

Investors